CANCER OF UNKNOWN PRIMARY SITE
Clinical trials for CANCER OF UNKNOWN PRIMARY SITE explained in plain language.
Never miss a new study
Get alerted when new CANCER OF UNKNOWN PRIMARY SITE trials appear
Sign up with your email to follow new studies for CANCER OF UNKNOWN PRIMARY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a new drug boost chemotherapy against mysterious cancers?
Disease control Recruiting nowThis trial is testing whether adding an experimental drug called F520 to standard chemotherapy (paclitaxel plus carboplatin) helps people with cancer of unknown primary — a cancer that has spread but whose original site cannot be found. About 402 adults aged 18 to 75 who have not…
Matched conditions: CANCER OF UNKNOWN PRIMARY SITE
Phase: PHASE2, PHASE3 • Sponsor: Shandong New Time Pharmaceutical Co., LTD • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Rare cancer hope: genetic tests may match patients to better treatments
Knowledge-focused Recruiting nowThis study is testing whether genetic testing of tumors and blood can help doctors choose better treatments for people with rare cancers. About 400 adults with rare solid tumors or lymphomas will have their tumors genetically analyzed. A team of experts will review the results an…
Matched conditions: CANCER OF UNKNOWN PRIMARY SITE
Phase: NA • Sponsor: TargetCancer Foundation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC